Rating Change
Mizuho analysts reiterated a Neutral rating on GRAIL, Inc. (NASDAQ:GRAL) on July 15, 2026.
Rating Change Mizuho analysts reiterated a Neutral rating on GRAIL, Inc. (NASDAQ:GRAL) on July 15, 2026. Market Context GRAIL, Inc.

Mizuho analysts reiterated a Neutral rating on GRAIL, Inc. (NASDAQ:GRAL) on July 15, 2026.
GRAIL, Inc. operates in the Healthcare sector. The stock currently trades at $74.36 with a market capitalization of $3.3B.
Analyst coverage from Mizuho provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for GRAIL, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 15, 2026 | Mizuho | Neutral | N/A |
| Jun 05, 2026 | Goldman Sachs | Neutral | N/A |
| May 06, 2026 | Piper Sandler | Neutral | N/A |
| May 06, 2026 | TD Cowen | Buy | N/A |
| Apr 10, 2026 | Mizuho | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View GRAL Stock Page
A Neutral rating from Mizuho reflects the analyst's outlook on GRAIL, Inc. (NASDAQ:GRAL). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the GRAL forecast page.
Current market data
NASDAQ · GRAL
$82.50
Up: +$2.91 · +3.66%
Live quote updated
Keep reading